JSLL vs SAKAR: Stock Comparison

Jeena Sikho Lifecare Limited vs Sakar Healthcare Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Jeena Sikho Lifecare Limited is the larger company by market capitalisation. Jeena Sikho Lifecare Limited shows a lower P/E, a higher ROE and a higher dividend yield, while Sakar Healthcare Limited shows lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Jeena Sikho Lifecare Limited and Sakar Healthcare Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, JSLL is more favourable on 9 of 13 scored metrics and SAKAR on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
JSLL is the larger company
₹6,904 Cr vs ₹1,799 Cr
P/E Ratio
JSLL has a lower P/E
31.29x vs 49.57x
P/B Ratio
SAKAR has a lower P/B
5.51x vs 14.86x
EPS
JSLL has higher earnings per share
₹17.79 vs ₹13.68
Dividend Yield
JSLL has a higher dividend yield
0.19% vs 0%
Revenue Growth (TTM YoY)
JSLL has faster revenue growth
54.8% vs 40.1%
EPS Growth (TTM YoY)
SAKAR has faster EPS growth
87.2% vs 77.5%
Qtr Sales Growth
JSLL has stronger quarterly sales growth
54.8% vs 41.5%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricJSLLSAKAR
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricJSLLSAKAR
Live Price₹554.8₹802.2
Day Change-0.89%-3.07%
Volume5.03 L5.47 L
52-Week High₹849.5₹960
52-Week Low₹492₹345.5
Distance from 52W High-34.69%-16.44%

Valuation

MetricJSLLSAKAR
Market Cap₹6,904 Cr₹1,799 Cr
P/E Ratio31.29x49.57x
P/B Ratio14.86x5.51x
EPS₹17.79₹13.68
Book Value₹37.57₹145.98
Dividend Yield0.19%0%

Growth

MetricJSLLSAKAR
Revenue Growth (TTM YoY)54.8%40.1%
EPS Growth (TTM YoY)77.5%87.2%
Qtr Sales Growth54.8%41.5%
Qtr Profit Growth78.1%91.3%

Profitability & Leverage

MetricJSLLSAKAR
ROE61.3%9.99%
ROCE64.1%12.7%
Net Margin27.68%12.11%
Operating Margin43.6%27.4%
Debt to Equity0.27x0.17x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricJSLLSAKAR
Promoter Holding63.62%52.52% 0.34 pp
FII Holding6.17% 0.14 pp12.13% 0.81 pp
DII Holding0.46% 0.35 pp11.37% 0.05 pp
Public Holding29.76% 0.2 pp23.98% 1.11 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Jeena Sikho Lifecare Limited and Sakar Healthcare Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.